FDA
-
FDA is Improving Interoperability to Enhance Patient Outcomes
A new initiative aims to build a “community of interoperability” to improve diagnostics and standards.
7m read -
FDA Responds to Tobacco Application Spikes
The agency’s tech posture is helping it review unexpected amounts of applications for new tobacco products.
7m read -
How AI, Data Are Boosting FDA's Regulatory Processes
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
36m listen -
Navigating the Regulatory Road to COVID-19 Booster Shots
Data management and digital tools are driving FDA’s efforts to respond to the next wave of COVID-19 demands.
7m read -
FDA Getting Ahead of Supply Chain Threats With New Program
A permanent supply chain program will help the agency prevent shortages of medical devices.
7m read -
How FDA is Approaching Change Management in New Data Efforts
Leveraging patient experience data for product development requires strong workforce readiness.
7m read -
How FDA Ramped up Medical Device Reviews
Following the onset of COVID-19, one office within the Food and Drug Administration leveraged new processes and developed innovative tools to support increased public health demands in regulating medical devices, leaders explained during FDA’s regulatory conference with industry this month.
7m read -
How FDA Ramped Up COVID-19 Treatment Approvals
When COVID-19 was declared a national emergency, the Food and Drug Administration had to act quickly on its oversight responsibilities around the sudden need for new testing, equipment and, ultimately, vaccines.
7m read -
Change Management Key to Transforming the Federal Workforce
As agencies modernize their IT infrastructure to remain competitive in the digital ecosystem, leaders are spearheading change management to ensure their workforce is up to speed.
7m read -
FDA Calls to Protect Drug Supply Chain During Pandemic
The Food and Drug Administration is advising industry partners on new guidance for identifying and tracing prescription drugs as they move through the distribution supply chain to ensure availability of critical drugs during the pandemic, Leigh Verbois, director of FDA’s Office of Drug Security, Integrity and Response, told GovernmentCIO Media & Research.
7m read -
COVID-19 Has Reshaped Federal Health IT Security
Changes brought by COVID-19 have produced a corresponding shift in federal cybersecurity posture, particularly among agencies responsible for overseeing health care and medical IT systems.
7m read -
FDA Tackles Training, Recruiting in Next Phase of Data Strategy
The Food and Drug Administration is breaking down silos, spearheading new data sharing efforts and upskilling its workforce under its data strategy to turn data into a “strategic asset” and drive new efficiencies.
7m read